Trial Profile
A study to assess the safety and efficacy of an investigational drug (MK-686) [MK-0686] in patients with osteoarthritis
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs MK 0686 (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 29 Sep 2006 New trial record.